Short answer
When designing interventions or products in fields influenced by external marketing, anticipate and account for the potential biases introduced by stakeholder interactions.
- Field
- Innovation & Markets
- Source
- PLoS ONE (2017)
- Method
- Systematic Review and Meta-analysis
- Evidence
- Moderate effect
Physician interactions with pharmaceutical companies are associated with a 2.5-fold increase in specific prescribing behaviors. This innovation & markets research insight is drawn from a 2017 study published in PLoS ONE. Using Systematic review and meta-analysis, researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing interventions or products in fields influenced by external marketing, anticipate and account for the potential biases introduced by stakeholder interactions.
Pharmaceutical marketing influences physician prescribing by 2.5x
Physician interactions with pharmaceutical companies are associated with a 2.5-fold increase in specific prescribing behaviors.
PLoS ONE · 2017
Key Findings
- 0115 out of 19 studies found a consistent association between pharmaceutical interactions and increased prescribing rates, lower prescribing quality, and/or increased prescribing costs.
- 02A meta-analysis of six studies showed a statistically significant association between exposure to pharmaceutical marketing and physicians' prescribing behaviors (OR = 2.52).
Application
Design takeaway
When designing interventions or products in fields influenced by external marketing, anticipate and account for the potential biases introduced by stakeholder interactions.
How to apply
In product development for regulated industries, consider how marketing and promotional activities might influence adoption and usage patterns. Design communication and training materials to emphasize objective data and evidence-based decision-making.
Project actions
- 01When researching a product's market, consider how promotional activities might influence its reception.
- 02Investigate potential conflicts of interest that could affect user behavior in your design project.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Comprehensive systematic review methodology.
- +Inclusion of a meta-analysis to quantify the association.
Limitations
The studies reviewed did not look at the actual health outcomes for patients, only the prescribing habits of doctors.
Reliability & validity
The meta-analysis provides a quantitative measure of association, but the overall evidence quality was downgraded due to risk of bias and inconsistency across the included observational studies.
Think critically
How might the design of pharmaceutical marketing materials themselves contribute to the observed changes in prescribing behavior?
Design Principles
"Marketing efforts can significantly alter professional decision-making; design strategies should aim to mitigate undue influence and promote objective evaluation."
Understanding the impact of marketing and stakeholder interactions is crucial for designing effective strategies in regulated industries. This insight highlights how external influences can shape professional decision-making, impacting product adoption and market dynamics.
What This Means for Your Design
Doctors who spend more time with drug company representatives tend to prescribe drugs in ways that cost more and might not be the best choice.
How to use in your project
- 1.Reference this study when discussing how market forces or stakeholder engagement might impact the adoption or use of a designed product or system.
Add to My Project
Quick Cite
Paragraph starter
This systematic review and meta-analysis by Brax et al. (2017) highlights a significant association between physicians' interactions with pharmaceutical companies and their prescribing practices. The findings indicate that such interactions can lead to a 2.5-fold increase in specific prescribing behaviors, often resulting in increased costs and potentially lower quality of care. This underscores the importance of considering external market influences and potential biases when designing and implementing new products or services within professional contexts.
Source
PLoS ONE
Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis
journal · 2017
View sourceQuestions About This Research
- What does the research say about pharmaceutical marketing influences physician prescribing by 2.5x?
- When designing interventions or products in fields influenced by external marketing, anticipate and account for the potential biases introduced by stakeholder interactions. Evidence: PLoS ONE (2017).
- Why does "Pharmaceutical marketing influences physician prescribing by 2.5x" matter for design?
- Understanding the impact of marketing and stakeholder interactions is crucial for designing effective strategies in regulated industries. This insight highlights how external influences can shape professional decision-making, impacting product adoption and market dynamics.
- How can designers apply this research?
- When designing interventions or products in fields influenced by external marketing, anticipate and account for the potential biases introduced by stakeholder interactions.
- What were the main findings?
- 15 out of 19 studies found a consistent association between pharmaceutical interactions and increased prescribing rates, lower prescribing quality, and/or increased prescribing costs.. A meta-analysis of six studies showed a statistically significant association between exposure to pharmaceutical marketing and physicians' prescribing behaviors (OR = 2.52).
- What research method was used?
- Systematic Review and Meta-analysis.
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2017 journal from PLoS ONE.
- What should I do differently in my next project?
- In product development for regulated industries, consider how marketing and promotional activities might influence adoption and usage patterns. Design communication and training materials to emphasize objective data and evidence-based decision-making.
- What are the limitations?
- The quality of evidence was moderate due to risk of bias and inconsistency across studies. None of the studies assessed direct clinical outcomes.